Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development.

US Deprescribing Research Network Announces 2024 Annual Meeting in Boston on May 15th

The US Deprescribing Research Network, co-led by UCSF division faculty member Mike Steinman, MD, welcomes you to attend its 2024 Annual Meeting, which will be held in-person on May 15th in Boston during the preconference day of the Society of General Internal Medicine Annual Meeting. This meeting, organized in coordination with SGIM, is open to both faculty and trainees interested in research on deprescribing and other ways of improving medication use among older adults. Past meetings have been very highly rated and this event provides a terrific opportunity to learn about ongoing research and opportunities in this area and to meet and network with colleagues across the US and the world who share these interests.

For more information and to register, please visit here. There is a nominal registration fee which is waived for trainees (see drop-down button at top of the page).

We also welcome and encourage people to submit abstracts for our poster session. This can include encore presentations of abstracts that were submitted to SGIM or other meetings.

Please reach out to us at [email protected] with any questions, and we would be delighted to see you there.

Characterization of Streptococcus gordonii SecA2 as a paralogue of SecA.

Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance.

Urearetics: a small molecule screen yields nanomolar potency inhibitors of urea transporter UT-B.

Low socioeconomic status and female sex are associated with worse functional status in axial spondyloarthritis.